Is the apparently protective effect of maternal nicotine replacement therapy (NRT) used in pregnancy on infant development explained by smoking cessation?: secondary analyses of a randomised controlled trial.

Iyen, Barbara; Vaz, Luis R; Taggar, Jaspal; Cooper, Sue; Lewis, Sarah; Coleman, Tim

Abstract

Objective: To investigate relationships between maternal smoking status in pregnancy and infant development. The largest RCT of nicotine replacement therapy (NRT) for smoking cessation in pregnancy, the Smoking and Nicotine in Pregnancy (SNAP) trial, found that at one month after randomisation, smoking cessation rates were doubled in the NRT group compared to the placebo group. At delivery, there was no significant difference in cessation rates between groups. Surprisingly, infants born to women randomised to NRT were more likely to have unimpaired development at 2 years. We hypothesized that this apparently protective effect was due to smoking cessation caused by NRT and so, investigate this relationship using the same cohort.

Design: Secondary analysis of a randomised controlled trial.

Setting: Seven antenatal hospitals in the Midlands and North-West England.

Participants: Eight hundred and eighty-four (884) pregnant smokers randomised to receive either NRT patches or visually-identical placebo in the SNAP trial. Participants’ smoking behaviour were recorded at randomisation, one month after their target quit date and at delivery.

Methods: Using logistic regression models, we investigated associations between participants’ smoking measures and infant development (assessed using the Ages and Stages questionnaire) at 2 years.

Main outcome measures: 2-year infant development.

Results: Developmental impairment was reported for 12.7% of study 2 year olds. Maternal heaviness of smoking at randomisation (odds ratio [OR]: 1.26, 95% confidence interval [95% CI]: 0.82-1.96, p = 0.091), validated smoking abstinence recorded at one month after a quit date (OR: 1.02, 95% CI: 0.60-1.74, p = 0.914) and validated smoking abstinence recorded at one month after a quit date and at the end of pregnancy (OR: 1.52, 95% CI: 0.81-2.85, p = 0.795) were not independently associated with infant developmental impairment at 2 years.

Conclusion: We found no evidence that NRT treatment improved infants' developmental outcomes through smoking cessation.

Citation

Iyen, B., Vaz, L. R., Taggar, J., Cooper, S., Lewis, S., & Coleman, T. (2019). Is the apparently protective effect of maternal nicotine replacement therapy (NRT) used in pregnancy on infant development explained by smoking cessation?: secondary analyses of a randomised controlled trial. BMJ Open, 9(7), Article e024923. https://doi.org/10.1136/bmjopen-2018-024923

• Journal Article Type: Article
• Acceptance Date: Jun 13, 2019
• Online Publication Date: Jul 11, 2019
• Publication Date: 2019-06
• Deposit Date: Jun 18, 2019
• Publicly Available Date: Jul 18, 2019
• Journal: BMJ Open
• Electronic ISSN: 2044-6055
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 9
• Issue: 7
• Article Number: e024923
• DOI: https://doi.org/10.1136/bmjopen-2018-024923
• Keywords: Smoking in pregnancy; Maternal smoking; Child development; Developmental impairment
• Public URL: https://nottingham-repository.worktribe.com/output/2202426
• Publisher URL: https://bmjopen.bmj.com/content/9/7/e024923